Uganda gives Sh10B to Mulago for drugs

19 August 2007

The government of Uganda has doubled the funding for drugs to Mulago Hospital from 5.0 billion shillings ($2.9 million) to 10.0 billion shillings this financial year, the Health State Minister, Richard Nduhura, has said, according to AllAfrica.Com.

Speaking at the celebrations to mark 40 years of the existence of the Uganda Cancer Institute at Mulago Hospital, Dr Nduhura said the institute would receive an additional 150.0 million shillings for the renovation of its premises.

"Cancer is a cause of morbidity and mortality and it contributes significantly to the burden of disease. The cost of providing cancer care is very high given its specialized nature," noted Dr, adding that many patients do not access quality cancer care due to the limited facilities. Mulago Hospital registers 20,000 new cases annually, although it has only 60 beds.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight